Respiratory News and Research

RSS

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.

16 Dec 2020

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Researchers at the University of Washington show that methylene blue (MB) and light can decontaminate masks and respirators by inactivating three tested coronaviruses without compromising integrity. The method is effective, low-cost, and does not require specialized equipment, making it applicable in any setting.

16 Dec 2020

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

UK-based researchers have found that providing clear information and practical or financial support could reduce the number of people who feel that they have to break lockdown rules. They have also evaluated the risk tied to engaging in a particular behavior.

16 Dec 2020

Using hypoxia adaptations in marine mammals to understand COVID-19

News-Medical talks to Terrie Williams about how the diving physiology that adapts marine mammals to hypoxia can improve our understanding of COVID-19.

16 Dec 2020

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.

From AXT Pty Ltd 16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month.

15 Dec 2020

SARS-CoV-2 unique deletion variants found in clinical specimens

While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.

15 Dec 2020

Neanderthal gene variant increases risk of severe COVID-19

Researchers in Germany have conducted a study showing that between 2 and 8% of people in Eurasia carry a genetic variant inherited from Neanderthals that significantly increases the risk of becoming critically ill with coronavirus disease 2019 (COVID-19).

15 Dec 2020

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Researchers from the University of Rochester, USA, has produced an AI-based study that analyzes the social media platform Twitter to gauge public opinions in the US surrounding SARS-CoV-2 vaccines to shed greater light on this issue.

15 Dec 2020

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

A team of US-based researchers recently conducted an illuminating study that explores this method and its potential uses. In doing so, they have underscored the potential utility of wastewater surveillance in managing SARS-CoV-2 outbreaks.

15 Dec 2020

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

During a Dec. 8 press conference about Operation Warp Speed, President Donald Trump likened the spread of the coronavirus throughout the population — which experts agree bestows some immunity on the people who became ill — to having a COVID-19 vaccine.

15 Dec 2020

Drug may increase vaccine protection in older adults

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.

15 Dec 2020

Researchers use HACCP framework to assess COVID-19 transmission risks in universities

Using the Hazard Analysis of Critical Control Points (HACCP) framework, researchers assessed the risk and mitigation strategies for universities with students returning to campus. The methodology allowed a rapid response to curb disease transmission with continuing education.

15 Dec 2020

Respiratory News and Research

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

Using hypoxia adaptations in marine mammals to understand COVID-19

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

RedHill Biopharma announces promising preliminary results from opaganib study

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

SARS-CoV-2 unique deletion variants found in clinical specimens

Neanderthal gene variant increases risk of severe COVID-19

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

Drug may increase vaccine protection in older adults

Researchers use HACCP framework to assess COVID-19 transmission risks in universities

Structural inequalities in Brazil linked to higher COVID-19-related mortality in low-income areas

Flavobac™ Cold & Flu Guard provides a natural barrier against bacteria and viruses

Environmental monitoring shows SARS-CoV-2 contamination of surfaces in food plants

UK government declares identification of a “new variant” of coronavirus

Reliable Antibodies Testing for SARS-CoV-2

Not all masks protect the same: Research suggests no mask better than an old mask

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News